Keyword: new medicines

News

Biogen Wins EU Backing for Big New MS Drug Hope

22.03.2013 - European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...

News

Antibiotics Crisis Prompts Rethink on Risks, Rewards

18.03.2013 - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...

News

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

26.01.2013 - Pharmaceutical industry productivity is improving as a more targeted approach to drug development yields dividends and regulators offer speedier decisions on medicines that make a...

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

Top-Selling Drugs for Ultra-Rare Diseases

03.01.2013 - Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...

News

Entering the Age of the $1 Million Medicine

03.01.2013 - The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...

News

US FDA New Drug Approvals Hit 16-Year High in 2012

02.01.2013 - U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...